Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Pharmaceutical Industry News ••• Topics • Countries • U.S. States

Rituximab News Monitoring

Get by Email • RSS

Published on May 8, 2025

Simple blood test could offer hope to patients with treatment-resistant lupus

A simple blood test could match people with lupus who do not respond to current treatments with an innovative combination of drugs, according to researchers. It is hoped the test, which looks for certain biomarkers in the blood, could help these patients …

Source: Express & Star - Neutral
Published on May 8, 2025

LUPKYNIS Strengthens Market Position As Demand For Lupus Nephritis Treatment Grows Delveinsight

(MENAFN- PR Newswire) As a novel calcineurin inhibitor with proven efficacy in improving renal outcomes, LUPKYNIS addresses a high unmet medical need. With increasing awareness, supportive guidelines, and potential global expansion, it is well-positioned …

Source: MENAFN - Indeterminate
Published on May 8, 2025

FDA Lifts Clinical Hold on Tabelecleucel Trial for EBV+ Post-Transplant Lymphoproliferative Disease

The FDA has lifted the clinical hold on an active investigational new drug application for the tabelecleucel (Ebvallo), allowing the resumption of clinical research for patients with Epstein-Barr virus (EBV)–positive post-transplant lymphoproliferative …

Source: OncLive - Pending
Published on May 7, 2025

FDA Lifts Clinical Hold on Tabelecleucel in EBV+ Lymphoproliferative Disease

The FDA has lifted its clinical hold on the investigational new drug applications for tabelecleucel (tab-cel; Ebvallo) as a treatment for those with Epstein-Barr Virus (EBV)–positive post-transplant lymphoproliferative disease (PTLD), according to a news …

Source: Cancer Network - New Jersey - Pending
Published on May 7, 2025

FDA Lifts Clinical Hold on Tab-Cel Application in EBV+ PTLD

The FDA has lifted the clinical hold on the investigational new drug (IND) application of tablecleucel (tab-cel; Ebvallo) for the treatment of Epstein-Barr Virus-associated post-transplant lymphoproliferative disease (EBV+ PTLD) The IND was placed on …

Source: Targeted Oncology - Pending
Published on May 7, 2025

EULAR Task Force Expands Pregnancy-Safe Drug Options

All tumor necrosis factor (TNF) inhibitors are safe to use throughout pregnancy, according to new recommendations from the European Alliance of Associations for Rheumatology (EULAR). All biologic disease-modifying antirheumatic drugs (bDMARDs) can also be …

Source: Medscape - Neutral
Published on May 6, 2025

Statins May Improve Survival in Patients With Chronic Lymphocytic Leukemia Receiving Ibrutinib

Statin therapies significantly improved overall survival (OS) and progression-free survival (PFS) in patients with chronic lymphocytic leukemia and small lymphocytic lymphoma (SLL; CLL/SLL) treated with ibrutinib (Imbruvica; Janssen Biotech, AbbVie). …

Source: Pharmacy Times - Neutral
Published on May 6, 2025

AstraZeneca Gets Approval For Oncology Drug To Treat Mantle Cell Lymphoma In EU: But Retail Sentiment Dips

The approval is based on positive results from a phase 3 trial, which demonstrated that Calquence plus bendamustine and rituximab reduced the risk of disease progression or death by 27% compared to standard-of-care chemoimmunotherapy. Shares of AstraZeneca …

Source: myMotherLode - Pending
Published on May 5, 2025

Mitigating Peripheral Neuropathy During Cancer Treatment

Waldenstrom macroglobulinemia, also referred to as WM, is a type of blood cancer classified under non-Hodgkin's lymphoma, and is also sometimes called lymphoplasmacytic lymphoma, according to the Mayo Clinic website. Waldenstrom macroglobulinemia …

Source: Cure Today - Neutral
Published on May 6, 2025

How to Choose Treatment Regimens for Idiopathic Membranous Nephropathy Patients with PLA2R-Negative: A Single-Center ...

Introduction Idiopathic membranous nephropathy (IMN) is an autoimmune kidney disease, and the treatment of this disease has made great progress in recent years.1 M-type phospholipase A2 receptor (PLA2R) is a major target antigen expressed in podocytes, and …

Source: Dove Medical Press - Neutral
Published on May 5, 2025

Navrogen Announces Publication on the CA125-Refractory NAV-006 Ab Treatment of Immunosuppressed Follicular Lymphoma

Navrogen Inc Announces Publication on the CA125-Refractory NAV-006 Antibody for the Treatment of Immunosuppressed Follicular Lymphoma CHEYNEY, PA, UNITED STATES, May 5, 2025 /⁨EINPresswire.com⁩/ -- Cheyney, PA, May, 5 2025 - Navrogen, Inc., a …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 7, 2025

Case Report Highlights Rare Case of Progressive Multifocal Leukoencephalopathy in Childhood NMOSD

Recently published in the Multiple Sclerosis Journal, investigators reported the first pediatric and fatal case of progressive multifocal leukoencephalopathy (PML) in a child with neuromyelitis optica spectrum disorder (NMOSD) 9 years after his initial …

Source: NeurologyLive - Pending
Published on May 7, 2025

Acalabrutinib Combo Receives EU Approval for Mantle Cell Lymphoma

Acalabrutinib (Calquence) plus bendamustine (Treanda) and rituximab (Rituxan) has received approval from the EU as a frontline treatment for adult patients with previously untreated mantle cell lymphoma (MCL) ineligible for autologous hematopoietic stem …

Source: Cancer Network - New Jersey - Pending
Published on May 6, 2025

Oncology Biosimilars Cut Costs; Diabetes and Other Diseases Could Follow

Biosimilars are gaining acceptance, and with oncology drugs exceeding 80% adoption, biosimilars in the US are saving the health care system $13 billion to $15 billion annually, according to Shreehas P. Tambe, MD, managing director and CEO at Biocon …

Source: The Center for Biosimilars - Pending
Published on May 6, 2025

Treanda side effects and how to manage them

Treanda can cause certain side effects, some of which are more common than others. These side effects may be temporary, lasting a few days to weeks. However, if the side effects persist, bother you, or become severe, be sure to talk with your doctor or …

Source: Medical News Today - Neutral
Published on May 5, 2025

Third-Line DLBCL Therapy Choice Depends on Access to Bispecifics

Krish Patel, MD Director of Lymphoma Research Executive Chair Lymphoma Research Executive Committee Sarah Cannon Research Institute Nashville, TN CASE SUMMARY A patient with diffuse large B-cell lymphoma (DLBCL) relapsed after first-line therapy and …

Source: Targeted Oncology - Pending
Published on Jan 2, 2025

Regulatory tracker: EMA restricts use of Valneva's Ixchiq in older adults, begins safety review

Welcome to Fierce Pharma's regulatory tracker for the first half of 2025. On this page, we're recording the regulatory progress of in-market products, including expansions into key geographies and new indications. Be sure to come back regularly for …

Source: Fierce Pharma - Neutral
Published on 00:14 GMT

Simple blood test offers new hope to lupus patients

Your support helps us to tell the story From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our …

Source: The Independent - Center-left
Published on May 8, 2025

Dr Kahl on the Outcomes of Bortezomib Plus BR in MCL

“The study showed that adding bortezomib to the bendamustine/rituximab induction did not improve the 2-year progression-free survival, [which] came in right around 75% to 80% in both arms, and [the bortezomib regimen] didn’t improve the complete …

Source: OncLive - Pending

03 days 20:30:28

Featured Releases

Got News to Share? · Submit · See All

Published on May 8, 2025 - 21:52 GMT

Meeting of the Oncologic Drugs Advisory Committee - 05/20/2025

Date: May 20 - 21, 2025 Day1: Tue, May 20 8:00 a.m. - 05:00 p.m. ET Day2: Wed, May 21 8:00 a.m. - 05:00 p.m. ET What is an advisory committee? Advisory committees provide independent expert advice to the FDA on broad scientific topics or on certain …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on May 8, 2025 - 20:17 GMT

Fennec Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025

RESEARCH TRIANGLE PARK, N.C., May 08, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will release its first quarter 2025 financial results …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on May 8, 2025 - 21:00 GMT

Apimeds Pharmaceuticals US, Inc. Announces Pricing of Initial Public Offering

Hopewell, New Jersey, May 08, 2025 (GLOBE NEWSWIRE) -- Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds” or the “Company”), a clinical stage biopharmaceutical company that is in the process of developing Apitox, an intradermally …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on May 8, 2025 - 20:05 GMT

Crinetics Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

Regulatory Interactions and Commercial, Medical, and Corporate Preparations On-Track for Paltusotine New Drug Application with September 25, 2025 PDUFA Date CALM-CAH Phase 3 Study of Atumelnant for the Treatment of Adults with Congenital Adrenal …

Distribution channels:

Published on May 8, 2025 - 20:05 GMT

Terns Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Updates

Initiated dose expansion in Phase 1 CARDINAL trial of TERN-701 in 2L+ CML Additional safety and efficacy data including 6-month MMR expected in 4Q25 Phase 2 FALCON trial of TERN-601 for obesity is enrolling well with top-line 12-week weight loss data …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on May 8, 2025 - 20:01 GMT

Shuttle Pharma FDA Orphan-Drug Nears Patient Enrollment Milestone for Phase 2 Clinical Trial

GAITHERSBURG, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 8, 2025 - 20:02 GMT

Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2025 Financial Results

Soquelitinib data from cohorts 1-3 of atopic dermatitis Phase 1 clinical trial demonstrate favorable safety and efficacy profile, including earlier and deeper responses in cohort 3 compared to cohorts 1-2 Phase 3 registrational clinical trial of …

Distribution channels:
Published on May 8, 2025 - 20:01 GMT

Corvus Pharmaceuticals Announces Data from Cohorts 1-3 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for ...

Data continue to demonstrate favorable safety and efficacy profile, including earlier and deeper responses in cohort 3 compared to cohorts 1-2 Data to be presented in an oral session and poster at the Society for Investigative Dermatology 2025 Annual …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Got news to share? Submit it now.

Load more pharmaceuticals news or search news using your own keywords. There are 810,997,034 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country

Pharmaceutical Industry News by U.S. State

Pharmaceutical Industry News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 04/18/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on May 9, 2025 - 05:51 GMT

Calite AI Launches on Apple App Store — Revolutionizing Nutrition Tracking with AI

Calite AI, the innovative AI-powered nutrition assistant, is now officially available on the Apple App Store. CHICAGO, IL, UNITED STATES, May 9, 2025 /⁨EINPresswire.com⁩/ -- Calite AI, the innovative AI-powered nutrition assistant, is now …

Distribution channels: Beauty & Hair Care, Culture, Society & Lifestyle ...
Published on May 9, 2025 - 05:30 GMT

Protein Purification and Isolation Market Poised to Triple by 2035: Biotech Breakthroughs & Personalized Medicine | FMI

Protein Purification and Isolation Market Insights – Size, Share & Forecast 2025 to 2035 NEWARK, DE, UNITED STATES, May 9, 2025 /⁨EINPresswire.com⁩/ -- The global protein purification and isolation market is on the verge of a transformative decade, …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 9, 2025 - 04:09 GMT

Tele911 Launches Fastest Path to Emergency Care in the U.S.

From Login to Live Board-Certified Emergency Room Physician in Under 40 Seconds PASADENA, CA, UNITED STATES, May 9, 2025 /⁨EINPresswire.com⁩/ -- In a bold step toward redefining emergency medical access, Tele911 today announced the launch of its …

Distribution channels: Emergency Services, Healthcare & Pharmaceuticals Industry ...
Published on May 9, 2025 - 04:03 GMT

Global Automated Cannabis Testing Market Set for Robust Growth, Projected to Achieve 11-13% CAGR from 2022 to 2032 | FMI

Automated Cannabis Testing Market Analysis – Growth & Trends 2022-2032 NEWARK, DE, UNITED STATES, May 9, 2025 /⁨EINPresswire.com⁩/ -- The global automated cannabis testing market is poised for significant expansion, with industry experts …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 9, 2025 - 04:03 GMT

Global Organ Transport Devices Market Poised for Growth to Reach USD 735.8 Million by 2035 at a CAGR of 4.9% | FMI

The Organ Transport Devices Market is segmented by devices, disposables, perfusion solutions, and region from 2025 to 2035 NEWARK, DE, UNITED STATES, May 9, 2025 /⁨EINPresswire.com⁩/ -- The global market for organ transport devices is witnessing …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 9, 2025 - 00:00 GMT

Renowned Neurosurgeon Dr. Mohana Rao (Dr. Rao) Chooses Guntur Over Global Metropolises, Revolutionizing Local Healthcare

Dr. Mohana Rao Patibandla's Quiet Revolution in Neurosurgery GUNTUR, ANDHRA PRADESH, INDIA, May 9, 2025 /⁨EINPresswire.com⁩/ -- Renowned Neurosurgeon Dr. Rao Chooses Guntur Over Global Metropolises, Revolutionizing Local Healthcare Dr. …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on May 8, 2025 - 23:32 GMT

Guardian Recovery Announces the Opening of Southern Maine Recovery Center in Westbrook, ME

Guardian Recovery, a leading provider of substance use disorder and mental health treatment announces the grand opening of Southern Maine Recovery Center. WESTBROOK, ME, UNITED STATES, May 8, 2025 /⁨EINPresswire.com⁩/ -- Guardian Recovery, a …

Distribution channels: Companies, Culture, Society & Lifestyle ...
Published on May 8, 2025 - 23:06 GMT

Guardian Recovery Welcomes Ross Bacon as Vice President of Business Development

Guardian Recovery announces the appointment of Ross Bacon as Vice President of Business Development bringing valuable expertise to support continued growth. DELRAY BEACH, FL, UNITED STATES, May 8, 2025 /⁨EINPresswire.com⁩/ -- Guardian Recovery …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on May 8, 2025 - 23:05 GMT

Guardian Recovery Announces Rebranding of Immersion Facilities in South Florida

Guardian Recovery announces the rebranding of two key treatment facilities in South Florida to further unify its expansive network of treatment facilities. DELRAY BEACH, FL, UNITED STATES, May 8, 2025 /⁨EINPresswire.com⁩/ -- Guardian Recovery …

Distribution channels: Companies, Culture, Society & Lifestyle ...
Published on May 8, 2025 - 22:27 GMT

Stem Health Plus Specializes in Care for Chronic Skin Conditions

Stem Health Plus Offers Specialized Care for Chronic Skin Conditions WONDER LAKE, IL, UNITED STATES, May 8, 2025 /⁨EINPresswire.com⁩/ -- Stem Health Plus proudly announces its expanded focus on treating chronic skin conditions through advanced …

Distribution channels: Emergency Services, Healthcare & Pharmaceuticals Industry ...
Published on May 8, 2025 - 22:24 GMT

Clean Remedies Announces Memorial Day Sale Honoring Veterans, Military, and Frontline Workers

Clean Remedies is proud to announce its upcoming Memorial Day Sale of 25% off sitewide, taking place from May 23 to May 26, 2025. AVON, OH, UNITED STATES, May 8, 2025 /⁨EINPresswire.com⁩/ -- Clean Remedies, a wellness company known for its plant- …

Distribution channels: Conferences & Trade Fairs, Consumer Goods ...
Published on May 8, 2025 - 22:21 GMT

Guardian Recovery's Chief Clinical Officer Featured on Huberman Lab Podcast

Ryan Soave, Chief Clinical Officer at Guardian Recovery, recently appeared as a guest expert on the influential Huberman Lab podcast. DELRAY BEACH, FL, UNITED STATES, May 8, 2025 /⁨EINPresswire.com⁩/ -- Ryan Soave, Chief Clinical Officer at …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on May 8, 2025 - 21:59 GMT

Guardian Recovery's New Pathway Counseling Centers Now In-Network With AmeriHealth

Guardian Recovery announces that their New Pathway Counseling Centers are now in-network with AmeriHealth insurance, expanding access to treatment services. PINE BROOK, NJ, UNITED STATES, May 8, 2025 /⁨EINPresswire.com⁩/ -- Guardian Recovery …

Distribution channels: Companies, Culture, Society & Lifestyle ...
Published on May 8, 2025 - 21:50 GMT

Guardian Recovery - Montville Adolescent Center Now In-Network With AmeriHealth

Guardian Recovery announces that its Montville Adolescent Center is now in-network with AmeriHealth insurance, expanding access for adolescents. MONTVILLE, NJ, UNITED STATES, May 8, 2025 /⁨EINPresswire.com⁩/ -- Guardian Recovery announces that its …

Distribution channels: Companies, Culture, Society & Lifestyle ...
Published on May 8, 2025 - 21:47 GMT

Comparing In-Office Teeth Whitening with Over-the-Counter Kits: What Sets Them Apart

SLIDELL, LA, UNITED STATES, May 8, 2025 /⁨EINPresswire.com⁩/ -- Teeth whitening remains one of the most requested cosmetic dental treatments in the United States. While over-the-counter whitening kits are widely available and often marketed as …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on May 8, 2025 - 21:11 GMT

Earth Buddy Offers CBD Products to Keep Pets Calm This Fourth of July

Earth Buddy is shining a light on the growing need for accessible education around using CBD for pets, especially when calming stressed-out pets. LONGMONT, CO, UNITED STATES, May 8, 2025 /⁨EINPresswire.com⁩/ -- Earth Buddy, a well-established pet …

Distribution channels: Consumer Goods, Culture, Society & Lifestyle ...
Published on May 8, 2025 - 21:08 GMT

Guardian Recovery - Dallas Addiction Center Now In-Network with Magellan Health Insurance

Guardian Recovery's Dallas Addiction Center announces In-network Status With Magellan Health insurance, significantly enhancing treatment accessibility. DALLAS, TX, UNITED STATES, May 8, 2025 /⁨EINPresswire.com⁩/ -- Guardian Recovery's …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on May 8, 2025 - 20:50 GMT

WellMedica Pioneers Sexual Wellness Treatments for Men and Women

WellMedica offers non-surgical treatments that support men's and women’s sexual wellness, addressing erectile dysfunction and hormonal changes. RESTON, VA, UNITED STATES, May 8, 2025 /⁨EINPresswire.com⁩/ -- In recent years, sexual wellness has …

Distribution channels: Beauty & Hair Care, Culture, Society & Lifestyle ...
Published on May 8, 2025 - 20:35 GMT

Pro Football Hall of Famer Terrell Davis Inspires Colorado Students and Promotes Schoolwide Mental Health Screening

DENVER, CO, UNITED STATES, May 8, 2025 /⁨EINPresswire.com⁩/ -- On April 30, Super Bowl MVP and Pro Football Hall of Famer Terrell Davis visited Colorado’s Conifer High School to connect with students and launch the Rising Together Schoolwide Mental …

Distribution channels: Culture, Society & Lifestyle, Education ...
Published on May 8, 2025 - 20:17 GMT

Nurses Week 2025 in Full Swing: Team Select Home Care Kicks Off the Celebration with Gifts, Giveaways, and Gratitude

Team Select Home Care celebrates Nurses Week 2025 with giveaways, gifts, and gratitude for in-home nurses making a difference every day. PHOENIX, AZ, UNITED STATES, May 8, 2025 /⁨EINPresswire.com⁩/ -- Nurses Week 2025 is in full force, and …

Distribution channels: Business & Economy, Education ...